ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

HZNP Horizon Therapeutics Public Limited Company

116.30
0.00 (0.00%)
Fuera de horario
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Horizon Therapeutics Public Limited Company HZNP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 116.30 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
116.30 116.30
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/10/202315:44EDGAR2Form 15-12G - Securities registration termination [Section..
09/10/202306:33IHMARKETNEWSMonday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers,..
06/10/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202317:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202316:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202316:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202315:30EDGAR2Form S-8 POS - Securities to be offered to employees in..
06/10/202315:05EDGAR2Form 8-K - Current report
06/10/202307:30BWRule 17(e) Announcement - Horizon Therapeutics plc
05/10/202306:40BWRule 17(d) Announcement – Horizon Therapeutics plc
05/10/202306:32EDGAR2Form 8-K - Current report
03/10/202310:15BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
03/10/202310:06BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
02/10/202310:39BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
02/10/202310:24BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
02/10/202307:00BWHorizon Therapeutics plc Announces New UPLIZNA®..
29/9/202310:45BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
29/9/202309:00BWNew Analysis Highlights Importance of Adhering to..
27/9/202308:45BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
26/9/202308:02BWHorizon Therapeutics plc Named to U.S. News & World Report’s..
25/9/202308:34BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
19/9/202307:00BWHorizon Therapeutics plc Ranks Number One on the Fortune..
13/9/202307:00PRNUSQ32 Bio and Horizon Therapeutics plc Announce Dosing of..
12/9/202306:30EDGAR2Form 8-K - Current report
06/9/202315:15BWHorizon Therapeutics plc (“Horizon”) Rule 2.12 Announcement
06/9/202306:20IHMARKETNEWSWednesday’s Wall Street Highlights: Verb Technology, Apple,..
05/9/202308:09EDGAR2Form 8-K - Current report
05/9/202308:05BWHorizon Therapeutics Announces Date of Irish Court Hearing..
01/9/202313:46DJNTrending: FTC Ends Challenge of Amgen/Horizon Deal
01/9/202308:21EDGAR2Form 8-K - Current report
01/9/202308:20PRNUSAMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT,..
28/8/202308:06IHMARKETNEWSMonday’s Wall Street Highlights: Jabil, Xpeng, 3M, Hostess..
23/8/202307:00BWHorizon Therapeutics plc Ranks First in Overall Corporate..
09/8/202309:30BWHorizon Therapeutics plc - Rule 2.12 Announcement
08/8/202307:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:11EDGAR2Form 8-K - Current report
08/8/202306:00BWHorizon Therapeutics plc Reports Second-Quarter 2023..
28/7/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202315:10EDGAR2Form 8-K - Current report
28/7/202310:55BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
28/7/202310:45BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
28/7/202310:35BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
28/7/202310:30BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
28/7/202310:20BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
28/7/202310:15BWRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)